Éric Bruckert

1988–2025 年に発表

別表記
Eric Bruckert
145
論文数
38,644
被引用数
89
h 指数
144
i10 指数

被引用数

Éric Bruckert の年別被引用数1985 年: 被引用 4 件1987 年: 被引用 2 件1989 年: 被引用 2 件1990 年: 被引用 2 件1991 年: 被引用 12 件1992 年: 被引用 13 件1993 年: 被引用 10 件1994 年: 被引用 13 件1995 年: 被引用 9 件1996 年: 被引用 30 件1997 年: 被引用 15 件1998 年: 被引用 10 件1999 年: 被引用 12 件2000 年: 被引用 20 件2001 年: 被引用 54 件2002 年: 被引用 84 件2003 年: 被引用 149 件2004 年: 被引用 180 件2005 年: 被引用 178 件2006 年: 被引用 197 件2007 年: 被引用 191 件2008 年: 被引用 179 件2009 年: 被引用 194 件2010 年: 被引用 235 件2011 年: 被引用 207 件2012 年: 被引用 189 件2013 年: 被引用 219 件2014 年: 被引用 243 件2015 年: 被引用 302 件2016 年: 被引用 394 件2017 年: 被引用 357 件2018 年: 被引用 363 件2019 年: 被引用 1,209 件2020 年: 被引用 1,373 件2021 年: 被引用 1,455 件2022 年: 被引用 1,179 件2023 年: 被引用 990 件2024 年: 被引用 1,500 件2025 年: 被引用 672 件2026 年: 被引用 70 件1986 年は被引用が無いため表示していません1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,340 件、この内訳の 20.4%中国: 引用元論文 1,112 件、この内訳の 6.8%イギリス: 引用元論文 1,082 件、この内訳の 6.6%イタリア: 引用元論文 1,005 件、この内訳の 6.1%フランス: 引用元論文 769 件、この内訳の 4.7%カナダ: 引用元論文 717 件、この内訳の 4.4%ドイツ: 引用元論文 683 件、この内訳の 4.2%オーストラリア: 引用元論文 552 件、この内訳の 3.4%オランダ: 引用元論文 548 件、この内訳の 3.3%スペイン: 引用元論文 486 件、この内訳の 3%日本: 引用元論文 363 件、この内訳の 2.2%デンマーク: 引用元論文 330 件、この内訳の 2%
0%20.4%その他 32.9%

分野

  • Medicine79.6%
  • Biochemistry, Genetics and Molecular Biology12.2%
  • Immunology and Microbiology2%
  • Nursing1.4%
  • Neuroscience1.3%
  • Agricultural and Biological Sciences0.6%
  • その他2.9%

トピック

  • Lipoproteins and Cardiovascular Health12.3%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7.6%
  • Liver Disease Diagnosis and Treatment6.1%
  • Adipokines, Inflammation, and Metabolic Diseases3%
  • Lipid metabolism and disorders2.9%
  • Cholesterol and Lipid Metabolism2.8%
  • その他65.3%

共著者

全論文

検索で開く
  1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2017 被引用: 3,840

  2. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2020 被引用: 1,527

  3. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2003 被引用: 3,011

  4. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 669

  5. Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , - Gastroenterology 2005 被引用: 2,078

  6. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 被引用: 331

  7. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Eric Bruckert, Ronald M. Krauss, Ulrich Laufs, Raul D. Santos, Winfried März, Connie B. Newman, M. John Chapman, Henry N. Ginsberg, M. John Chapman, Henry N. Ginsberg, Guy De Backer, Alberico L. Catapano, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Lawrence A. Leiter, François Mach, Olov Wiklund - European Heart Journal 2015 被引用: 1,420

  8. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrich Julius, John P. Kane, Michel Krempf, Steven W. Martin, James J. Powell, Richard Shultzaberger, Craig Thompson, Letitia Thompson-Hargrave, Peter P. Tóth, Traci Turner, René Valéro, Bruno Vergès, Frank L.J. Visseren, Pankaj Vyas, Alberto R. Yataco - The Lancet Diabetes & Endocrinology 2021 被引用: 226

  9. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nessima Yelles, Éric Bruckert - New England Journal of Medicine 2019 被引用: 565

  10. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

    著者: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2016 被引用: 835

  11. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pablo Corral, Kairat Davletov, Olivier Descamps, Ronen Durst, М. В. Ежов, Dan Gaiță, Jacques Genest, Urh Grošelj, Mariko Harada‐Shiba, Kirsten B. Holven, Meral Kayıkçıoğlu, Weerapan Khovidhunkit, Katarina Lalić, Gustavs Latkovskis, Ulrich Laufs, Evangelos Liberopoulos, Marcos M. Lima-Martínez, Jie Lin, Vincent Maher, Adéle Marais, Winfried März, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, Hapizah Nawawi, Børge G. Nordestgaard, Andrie G. Panayiotou, György Paragh, Žaneta Petrulionienė, Belma Pojskić, Arman Postadzhiyan, Katarı́na Rašlová, Ashraf Reda, Željko Reiner, Fouzia Sadiq, Wilson E. Sadoh, Heribert Schunkert, Aleksandr B. Shek, Mario Stoll, Erik S.G. Stroes, Ta‐Chen Su, Tavintharan Subramaniam, Andrey V. Susekov, Myra Tilney, Brian Tomlinson, Thanh Huong Truong, Alexandros D. Tselepis, Anne Tybjærg‐Hansen, Alejandra Cárdenas, Margus Viigimaa, Luya Wang, Shizuya Yamashita, John J.P. Kastelein, Éric Bruckert, Branislav Vohnout, Laura Schreier, Jing Pang, Christoph Ebenbichler, Hans Dieplinger, Reinhold Innerhofer, Yvonne Winhofer-Stöckl, Susanne Greber‐Platzer, Konstantin A. Krychtiuk, Walter S. Speidl, Hermann Toplak, Kurt Widhalm, Thomas M. Stulnig, Kurt Huber, Florian Höllerl, Gersina Rega‐Kaun ほか 624 名 - The Lancet 2021 被引用: 305

  12. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daisy Rymen, Peter Witters, Raúl D. Santos, Liam R. Brunham, Gordon A. Francis, Jacques Genest, Robert A. Hegele, Brooke A. Kennedy, Isabelle L. Ruel, Mark Sherman, Long Jiang, Luya Wang, Željko Reiner, V. Bláha, R Češka, Jana Dvořáková, Lubomir Dlouhy, Pavel Hořák, Vladimír Soška, Lukáš Tichý, Robin Urbánek, H Vaverková, Michal Vrablı́k, Stanislav Zemek, Lukáš Zlatohlávek, Sameh Emil, Tarek Naguib, Ashraf Reda, Sophie Béliard, Éric Bruckert, Antonio Gallo, Moses Elisaf, Genovefa Kolovou, Hofit Cohen, Ronen Durst, Eldad J. Dann, Avishay Elis, Osama Hussein, Eran Leitersdorf, Daniel Schurr, Nitika Setia, Ishwar C. Verma, Mohammed Alareedh, Mutaz Al-Khnifsawi, Ali Fawzi Abdalsahib Al-Zamili, Sabah H. Rhadi, Foaad Shaghee, Marcello Arca, Maurizio Averna, Andrea Bartuli, Marco Bucci, Paola Sabrina Buonuomo, Paolo Calabrò, S. Calandra, Manuela Casula, Alberico L. Catapano, Angelo B. Cefalù, Arrigo F.G. Cicero, Sergio D’Addato, Laura D’Erasmo, Alessia Di Costanzo, Tommaso Fasano, Marta Gazzotti, Antonina Giammanco, Gabriella Iannuzzo, Anastasia Ibba, Emanuele Alberto Negri, Andrea Pasta, Chiara Pavanello, Livia Pisciotta ほか 73 名 - The Lancet 2022 被引用: 207

  13. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anne Tybjærg‐Hansen, Olov Wiklund - European Heart Journal 2015 被引用: 870

  14. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2018 被引用: 381

  15. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance

    著者: , , , , , , , , , , , , , , , , , , - JAMA 2016 被引用: 511

  16. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia, M. Cuchel, Éric Bruckert, M. John Chapman, O. S. Descamps, H. N. Ginsberg, Robert A. Hegele, Jan Albert Kuivenhoven, B. G. Nordestgaard, F. J. Raal, R. D. Santos, E. Steinhagen-Thiessen, Anne Tybjærg‐Hansen, Gerald F. Watts, M. John Chapman, Henry N. Ginsberg, Maurizio Averna, Cathérine Boileau, J. Boren, Alberico L. Catapano, Joep C. Defesche, G. K. Hovingh, Steve E. Humphries, Petri T. Kovanen, L. Masana, P. Pajukanta, Klaus G. Parhofer, Kausik K. Ray, Anton F. H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Albert Wiegman, Olov Wiklund - European Heart Journal 2014 被引用: 1,053

  17. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

    著者: , , , , , , , , , , , , - Journal of clinical lipidology 2015 被引用: 467

  18. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”

    著者: , , , , , , , , , , , , , , , , , , , , , , - Atherosclerosis 2018 被引用: 242

  19. Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study

    著者: , , , , - Cardiovascular Drugs and Therapy 2005 被引用: 1,240

  20. Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

    著者: , , , , , , , , , , , - Gastroenterology 2008 被引用: 622

  21. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Atherosclerosis 2019 被引用: 238

  22. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2013 被引用: 634

  23. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djurić, Ronen Durst, М. В. Ежов, Zlatko Fras, Dan Gaiță, Ioanna Gouni‐Berthold, Adrían V. Hernández, Steven R. Jones, Jacek Jerzy Jozwiak, N. Kakauridze, Amani Kallel, Niki Katsiki, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martínez, Mohsen Mazidi, Dimitri P. Mikhailidis, Erkin М Мirrakhimov, André R. Miserez, Olena Mitchenko, N. P. Mitкоvsкаyа, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Peter E. Penson, Žaneta Petrulionienė, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenković, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Manfredi Rizzo, Massimiliano Ruscica, Amirhossein Sahebkar, Maria-Corina Șerban, Abdullah Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Peter P. Tóth, Margus Viigimaa, Pedro Valdivielso, Dragoş Vinereanu, Branislav Vohnout, Stephan von Haehling, Michal Vrablı́k, Nathan D. Wong, Hung‐I Yeh, Jiang Zhisheng, Andreas Zirlik - Pharmacological Research 2023 被引用: 68

  24. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Chemistry 2018 被引用: 258